Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-06-000098
Filing Date
2006-11-17
Accepted
2006-11-17 14:58:17
Documents
1
Period of Report
2006-11-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 7761
  Complete submission text file 0000875320-06-000098.txt   9419
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139 6174446100
MUELLER PETER (Reporting) CIK: 0001256126 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 061226341